Stocks · News reference
Kiora Pharmaceuticals Released Preclinical Data Showing That KIO-300 Significantly Suppressed Seizure-associated Electrophysiological Activity In An Ex Vivo Temporal Lobe Epilepsy Model
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jun 18, 2026, 11:07 AM
- Checked
- Jun 18, 2026, 11:10 AM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading